Study details better outcomes for Omicron BA.2 patients — Harvard Gazette

Will Omicron BA.2 become the next dominant variant?

The new Omicron subvariant BA.2: what we know so far

Study reveals increased immunity evasion by Omicron BA.2.75.2

Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS

Omicron infection enhances Delta antibody immunity in vaccinated

The Coronavirus Update Archives — Harvard Gazette

Booster needed to neutralize the fast-spreading variant

Protective Effect of Previous SARS-CoV-2 Infection against Omicron

Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1

The features of the newly emerging SARS-CoV-2 Omicron BA.2.75

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron

New coronavirus subvariants escape antibodies from vaccination and

The ability of therapeutic monoclonal antibodies to neutralize